Vin-5 Nob Hill Therapeutics Financing
Vin-5 Nob Hill Therapeutics, Llc, Limited Liability Company just had published form D for $250,000 equity financing. This is a new filing. Vin-5 Nob Hill Therapeutics was able to fundraise $112,500 so far. That is 45.00% of the financing round. The total private offering amount was $250,000. The private financing document was filed on 2016-10-31. The reason for the financing was: unspecified. The fundraising still has about $137,500 more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Vin-5 Nob Hill Therapeutics is based in Arkansas. The firm’s business is not disclosed. The SEC form was submitted by R Calvin Goforth Manager. The company was incorporated in 2016. The filler’s address is: 535 W Research Center Blvd., Suite 135, Fayetteville, Ar, Arkansas, 72701. R. Calvin Goforth is the related person in the form and it has address: 535 W. Research Center Blvd., Suite 135, Fayetteville, Ar, Arkansas, 72701. Link to Vin-5 Nob Hill Therapeutics Filing: 000168887916000001.
Analysis of Vin-5 Nob Hill Therapeutics Offering
On average, firms in the not disclosed sector, sell 67.77% of the total offering amount. Vin-5 Nob Hill Therapeutics sold 45.00% of the offering. The financing is still open. The average offering size for companies in all industries in our database is $3.05 million. The offering was 96.31% smaller than the average of $3.05 million. Of course this should not be seen as negative. Firms raise funds for different needs and reasons. The minimum investment for this offering is set at $6250. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Vin-5 Nob Hill Therapeutics Also
The Form D signed by R Calvin Goforth might help Vin-5 Nob Hill Therapeutics, Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.